81
Participants
Start Date
February 2, 2021
Primary Completion Date
February 6, 2023
Study Completion Date
March 9, 2023
Ketamine use in CLCC sites (indication and administration protocol)
"Collection of information concerning Ketamine use by French CLCCs pain teams (first prescription):~1. Indications : analgesic treatment of cancer chronic pain, analgesic treatment for a post-cancer treatment chronic pain, help for withdrawal from opioid treatment prescribed for a chronic cancer pain~2. Administration protocol: route, posology, duration, administration sequence, premedication~3. Antalgic efficacy~4. Tolerance profile~5. Quality of life, anxiety and depression evaluations"
Institut Paoli Calmettes, Marseille
Institut Universitaire du Cancer (IUCT), Toulouse
Institut Bergonié, Bordeaux
Institut de Cancérologie de Montpellier, Montpellier
Centre Eugène Marquis, Rennes
Institut Godinot, Reims
Institut de Cancérologie de Lorraine Alexis Vautrin, Vandœuvre-lès-Nancy
Centre Jean Perrin, Clermont-Ferrand
Centre Leon Berard, Lyon
Institut Curie, Paris
Institut Gustave Roussy, Villejuif
Centre François Baclesse, Caen
Centre Leon Berard
OTHER